Fate Therapeutics Inc (NASDAQ:FATE) currently has a daily average trading volume of 1.93M but it saw 5885634 shares traded in last market. With a market cap of 427.06M USD, the company’s current market price of $3.17 came rising about 18.28 while comparing to the previous closing price of $2.68. In past 52 weeks, the stock remained buoying in the range of price level as high as $8.83 and as low as $1.96. In the recent trading on the day, stock has struck highest price mark of $2.68 while lowest mark touched by it was $3.27.
Taking a look at 20-day trading activity of Fate Therapeutics Inc (FATE) gives us an average price of $2.43, while its current price level is -64.10% below from 52-week high level whereas it is 61.73% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $2.88 while that of 200 days or SMA-200 reads an average of $4.33. A closer look into the stock’s movement over the week reveals that its volatility is standing at 18.82% during that period while stretching the period over a month that decreases to 15.21%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 63.09 which implies that the stock is in neutral territory.
Piper Sandler upgraded its recommendation for the stock as a “Overweight” from “Neutral” on June 17, 2024 while assigning a price target range of $4-$6. Wells Fargo issued its recommendations for the stock as it resumed the price target for the stock is $6.
Over the week, FATE’s stock price is moving 42.79% up while it is 16.54% when we observe its performance for the past one month. Year-to-date it is -15.24% down and over the past year, the stock is showing an upside performance of 25.30%.
Currently, Fate Therapeutics Inc’s total number of outstanding shares is 98.63M. Company’s return on investment (ROI) stands at -39.22% and return on equity (ROE) at -46.59%. Stock’s beta reads 1.89. Stock has a price to book (P/B) ratio of 1.00 while price to sale or P/S ratio amounts to 31.75. Its return on asset (ROA) is -34.32% on average.
